Dose dense chemotherapy in Luminal B breast cancers | Cancerworld Magazine
Overall survival depends on tumor subtype and systemic treatment. a... | Download Scientific Diagram
Valeur pronostique de la réponse histologique complète (pCR) sur la... | Download Scientific Diagram
Kaplan–Meier overall survival by breast cancer subtypes. 5-year overall... | Download Scientific Diagram
Ten‐year recurrence rates for breast cancer subtypes in the Netherlands: A large population‐based study - Maaren - 2019 - International Journal of Cancer - Wiley Online Library
Les 12 questions les plus souvent posées sur le cancer du #sein en consultation - HC Ceuta, Centro Médico de Especialidades | Centro Médico de Especialidades
Ki‑67 index value and progesterone receptor status can predict prognosis and suitable treatment in node‑negative breast cancer patients with estrogen receptor‑positive and HER2‑negative tumors
Cancers | Free Full-Text | Breast Cancer in Elderly Caucasian Women—An Institution-Based Study of Correlation between Breast Cancer Prognostic Markers, TNM Stage, and Overall Survival
Frontiers | Prognostic Relevance of Progesterone Receptor Levels in Early Luminal-Like HER2 Negative Breast Cancer Subtypes: A Retrospective Analysis
Les 12 questions les plus souvent posées sur le cancer du #sein en consultation - HC Ceuta, Centro Médico de Especialidades | Centro Médico de Especialidades
Breast cancer survival by molecular subtype: a population-based analysis of cancer registry data. - Abstract - Europe PMC
Long-term survival and stage I breast cancer subtypes - ScienceDirect
The influence of stage at diagnosis and molecular subtype on breast cancer patient survival: a hospital-based multi-center study | Cancer Communications | Full Text
Luminal B subtype: A key factor for the worse prognosis of young breast cancer patients in China | BMC Cancer | Full Text
Molecular subtypes, histopathological grade and survival in a historic cohort of breast cancer patients | Breast Cancer Research and Treatment
Disease-free survival curves of luminal type A and B breast cancer. | Download Scientific Diagram
Relapse-free survival in luminal A-like versus luminal B-like breast... | Download Scientific Diagram
Characteristics and outcomes according to molecular subtypes of breast cancer as classified by a panel of four biomarkers using immunohistochemistry - ScienceDirect
Long-term survival and stage I breast cancer subtypes - ScienceDirect
Relationship Between Molecular Subtypes and Overall Survival of Breast Cancer in Bandung – Biomedical and Pharmacology Journal
The CINSARC signature predicts the clinical outcome in patients with Luminal B breast cancer | npj Breast Cancer
A Nomogram for Predicting Liver Metastasis of Lymph-Node Positive Luminal B HER2 Negative Subtype Breast Cancer by Analyzing the Clinicopathological Characteristics of Patients with Breast Cancer - Yuhan Yue, Junqing Liang, Yuruo
Clinical Outcomes Among Major Breast Cancer Subtypes After Neoadjuvant Chemotherapy: Impact on Breast Cancer Recurrence and Survival | Anticancer Research
The regrouping of Luminal B (HER2 negative), a better discriminator of outcome and recurrence score - Yang - 2023 - Cancer Medicine - Wiley Online Library
PinPointcases - INACTIVE --- Adjuvant systemic treatment of luminal A/B early breast cancer
The CINSARC signature predicts the clinical outcome in patients with Luminal B breast cancer | npj Breast Cancer
